Table 3:
Severity of chronic microvascular ischemic disease in patients and controls
Subjects
None
Mild
Moderate
Severe
Patients with COVID-19
0.50
0.25
0.167
0.83
Controls with anosmia
0.333
0.417
0.25
0.00